Reference (Jul-21-A3)
Wang T, Hou J, Su C, Zhao L, Shi Y. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. J Nanobiotechnology. 2017;15(1):1–12.
Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, et al. Vascular toxicities of cancer therapies: The old and the new – An evolving avenue. Circulation. 2016;133(13):1272–89.
Devarajan P V, Dandekar P. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. 2019. 564 p.
Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol [Internet]. 2010;7(11):653–64. Available from: http://dx.doi.org/10.1038/nrclinonc.2010.139
López V, Villegas MR, RodrÃguez V, Villaverde G, Lozano D, Baeza A, et al. Janus Mesoporous Silica Nanoparticles for Dual Targeting of Tumor Cells and Mitochondria. ACS Appl Mater Interfaces. 2017;9(32):26697–706.
Xu Y, Wang S, Chan HF, Liu Y, Li H, He C, et al. Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery. Int J Pharm [Internet]. 2017;522(1–2):21–33. Available from: http://dx.doi.org/10.1016/j.ijpharm.2017.01.064
Tan Y, Zhu Y, Zhao Y, Wen L, Meng T, Liu X, et al. Mitochondrial alkaline pH-responsive drug release mediated by Celastrol loaded glycolipid-like micelles for cancer therapy. Biomaterials [Internet]. 2018;154:169–81. Available from: https://doi.org/10.1016/j.biomaterials.2017.07.036
Yamada Y, Munechika R, Kawamura E, Sakurai Y, Sato Y, Harashima H. Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity. J Pharm Sci [Internet]. 2017;106(9):2428–37. Available from: http://dx.doi.org/10.1016/j.xphs.2017.04.058
Qu Q, Ma X, Zhao Y. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers. Nanoscale. 2015;7(40):16677–86.
